|GSK1120212 vs Chemotherapy in Advanced or Metastatic BRAF V600E/K Mutation-positive Melanoma||
||322||All||18 Years and older (Adult, Senior)||NCT01245062||114267||November 22, 2010||October 26, 2011||December 16, 2016||November 22, 2010||October 25, 2017||March 15, 2013||
|2||NCT02036086||Recruiting||Study of Neo-adjuvant Use of Vemurafenib Plus Cobimetinib for BRAF Mutant Melanoma With Palpable Lymph Node Metastases||
||20||All||18 Years and older (Adult, Senior)||NCT02036086||ML28606||August 2015||October 2022||October 2022||January 14, 2014||January 23, 2018||
† Study has passed its completion date and status has not been verified in more than two years.